$240.20 B
Share price
Change (1 day)
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2021 (TTM): $9.68 B

According to AbbVie's latest financial reports the company's current earnings (TTM) are $9.68 B. In 2020 the company made an earning of $5.85 B a decrease over its 2019 earnings that were of $10.21 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for AbbVie from 2011 to 2021

Year Earnings Change
2021 (TTM)$9.68 B65.46%
2020$5.85 B-42.68%
2019$10.21 B56%
2018$6.54 B-26.26%
2017$8.87 B-0.62%
2016$8.93 B21.28%
2015$7.36 B163.09%
2014$2.79 B-50.3%
2013$5.63 B-1.48%
2012$5.71 B33.16%
2011$4.29 B